Aschoff P - Search Results

1

Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CT.

Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller-Horvat C, Steidle G, Horger M, Schafer J, Eschmann SM, Kiefer B, Claussen CD, Pfannenberg C, Schlemmer HP. Lichy MP, et al. Among authors: aschoff p. Invest Radiol. 2007 Sep;42(9):605-13. doi: 10.1097/RLI.0b013e31804ffd49. Invest Radiol. 2007. PMID: 17700275

2

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.

Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP. Pfannenberg C, et al. Among authors: aschoff p. Eur J Cancer. 2007 Feb;43(3):557-64. doi: 10.1016/j.ejca.2006.11.014. Epub 2007 Jan 16. Eur J Cancer. 2007. PMID: 17224266

3

Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results.

Plathow C, Aschoff P, Lichy MP, Eschmann S, Hehr T, Brink I, Claussen CD, Pfannenberg C, Schlemmer HP. Plathow C, et al. Among authors: aschoff p. Invest Radiol. 2008 May;43(5):290-7. doi: 10.1097/RLI.0b013e318163273a. Invest Radiol. 2008. PMID: 18424949 Clinical Trial.

4

Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.

Plathow C, Staab A, Schmaehl A, Aschoff P, Zuna I, Pfannenberg C, Peter SH, Eschmann S, Klopp M. Plathow C, et al. Among authors: aschoff p. Invest Radiol. 2008 Oct;43(10):737-44. doi: 10.1097/RLI.0b013e3181817b3d. Invest Radiol. 2008. PMID: 18791416

5

Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.

Aschoff P, Plathow C, Beyer T, Lichy MP, Erb G, Öksüz MÖ, Claussen CD, Pfannenberg C. Aschoff P, et al. Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):316-25. doi: 10.1007/s00259-011-1919-5. Epub 2011 Nov 29. Eur J Nucl Med Mol Imaging. 2012. PMID: 22124778

6

Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?

Brendle CB, Aschoff P, Kratt T, Schraml C, Reimold M, Claussen CD, Pfannenberg CA. Brendle CB, et al. Among authors: aschoff p. Korean J Radiol. 2013 Nov-Dec;14(6):951-9. doi: 10.3348/kjr.2013.14.6.951. Epub 2013 Nov 5. Korean J Radiol. 2013. PMID: 24265572 Free PMC article.

7

Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer.

Pfannenberg AC, Aschoff P, Brechtel K, Müller M, Bares R, Paulsen F, Scheiderbauer J, Friedel G, Claussen CD, Eschmann SM. Pfannenberg AC, et al. Among authors: aschoff p. Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):36-44. doi: 10.1007/s00259-006-0186-3. Epub 2006 Aug 1. Eur J Nucl Med Mol Imaging. 2007. PMID: 16896664

8

Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspects.

Brechtel K, Heners H, Mueller M, Aschoff P, Eschmann SM, Bares R, Claussen CD, Pfannenberg AC. Brechtel K, et al. Among authors: aschoff p. Nucl Med Commun. 2007 Feb;28(2):141-7. doi: 10.1097/MNM.0b013e328013eb09. Nucl Med Commun. 2007. PMID: 17198356

9

Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.

Lichy MP, Anastasiadis AG, Aschoff P, Sotlar K, Eschmann SM, Pfannenberg C, Stenzl A, Claussen CD, Schlemmer HP. Lichy MP, et al. Among authors: aschoff p. Urology. 2007 Jun;69(6):1208.e5-8. doi: 10.1016/j.urology.2007.03.009. Urology. 2007. PMID: 17572221

10

(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Pfannenberg C, Königsrainer I, Aschoff P, Oksüz MO, Zieker D, Beckert S, Symons S, Nieselt K, Glatzle J, Weyhern CV, Brücher BL, Claussen CD, Königsrainer A. Pfannenberg C, et al. Among authors: aschoff p. Ann Surg Oncol. 2009 May;16(5):1295-303. doi: 10.1245/s10434-009-0387-7. Epub 2009 Feb 28. Ann Surg Oncol. 2009. PMID: 19252950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page